Settlement Reached Over Cancer Test Patents

Law360, New York (January 8, 2007, 12:00 AM EST) -- Medical testing company PreMD Inc. has entered into a licensing agreement with an inventor, thus resolving a long-running dispute over patents related to tests for detecting breast, lung and colorectal cancer.

The Toronto-based company, which manufactures tests for detecting life-threatening illnesses, said it will retain the exclusive rights to its ColorectAlert and LungAlert tests, as well as breast cancer test technologies, as part of the agreement.

PreMD said the new agreement amended an earlier licensing agreement with the patents’ inventor, Abulkalam Shamsuddin, relating to two U.S....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.